Eosinophilic lung diseases

Medical Clinics of North America

Volumn 95, Issue 6, 2011, Pages 1163-1187

  Fernández Pérez, Evans R ^a   Olson, Amy L ^a,b   Frankel, Stephen K ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Allergic bronchopulmonary aspergillosis; Churg Strauss syndrome; Eosinophilic lung disease; Eosinophilic pneumonia; Eosinophils; Hypereosinophilic syndrome

Indexed keywords

ALPHA INTERFERON; AMIODARONE; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; BLEOMYCIN; CAMPTOTHECIN; CARBAMAZEPINE; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETHAMBUTOL; IBUPROFEN; INDOMETACIN; INFLIXIMAB; ISONIAZID; NAPROXEN; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTAMIDINE; PHENYTOIN; PIROXICAM; SULFONAMIDE; SULINDAC; TETRACYCLINE; UNINDEXED DRUG; VENLAFAXINE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; BRONCHOSCOPY; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EOSINOPHILIA; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; INFECTION; LOEFFLER PNEUMONIA; LUNG FUNCTION; LUNG LAVAGE; PRIORITY JOURNAL; REVIEW;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; BRONCHOSCOPY; CHURG-STRAUSS SYNDROME; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EOSINOPHILIA; HUMANS; HYPEREOSINOPHILIC SYNDROME; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; PULMONARY ALVEOLI; PULMONARY EOSINOPHILIA; RESPIRATORY TRACT INFECTIONS; RHEUMATIC DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82455172267     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2011.08.006     Document Type: Review

References (131)

1. Li H., Groshong S.D., Lynch D., et al. Eosinophilic lung disease. Clin Pulm Med 2010, 17(2):66-74.
2. Chang H.W., Leong K.H., Koh D.R., et al. Clonal origin of eosinophils in the hypereosinophilic syndrome detected by PCR analysis of DNA polymorphisms of the X linked human androgen receptor gene. Int J Hematol 1996, 64:S43.
3. Chang H.W., Leong K.H., Koh D.R., et al. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood 1999, 93:1651-1657.
4. Kagohashi K., Ohara G., Kurishima K., et al. Chronic eosinophilic pneumonia with subpleural curvilinear shadow. Acta Medica (Hradec Kralove) 2011, 54(1):45-48.
5. Johkoh T., Muller N.L., Akira M., et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000, 216(3):773-780.
6. Marmursztejn J., Vignaux O., Cohen P., et al. Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients. Clin Exp Rheumatol 2009, 27(1 Suppl 52):S70-S76.
7. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1990, 141(5 Pt 2):S169-S202.
8. Kwong Y.L., Chan L.C. Involvement of eosinophils in acute myeloid leukemia with monosomy 7 demonstrated by fluorescence in situ hybridization. Br J Haematol 1994, 88:389-391.
9. Luppi M., Marasca R., Morselli M., et al. Clonal nature of hypereosinophilic syndrome. Blood 1994, 84:349-350.
10. Giembycz M.A., Lindsay M.A. Pharmacology of the eosinophil. Pharmacol Rev 1999, 51(2):213-340.
11. Kariyawasam H.H., Robinson D.S. The eosinophil: the cell and its weapons, the cytokines, its locations. Semin Respir Crit Care Med 2006, 27(2):117-127.
12. Lams B.E., Sousa A.R., Rees P.J., et al. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158(5 Pt 1):1518-1523.
13. Dippolito R., Foresi A., Chetta A., et al. Eosinophils in induced sputum from asymptomatic smokers with normal lung function. Respir Med 2001, 95(12):969-974.
14. Komadina K.H., Houk R.W., Vicks S.L., et al. Goodpasture's syndrome associated with pulmonary eosinophilic vasculitis. J Rheumatol 1988, 15(8):1298-1301.
15. Travis W.D. Pathology of pulmonary vasculitis. Semin Respir Crit Care Med 2004, 25(5):475-482.
16. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009, 135(3):805-826.
17. Gibson P.G., Wark P.A., Simpson J.L., et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J 2003, 21(4):582-588.
18. Chauhan B., Santiago L., Hutcheson P.S., et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000, 106(4):723-729.
19. Eaton T.E., Weiner Miller P., Garrett J.E., et al. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis?. Clin Exp Allergy 2002, 32(5):756-761.
20. Tomee J.F., Kauffman H.F. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000, 30(4):476-484.
21. Mitchell T.A., Hamilos D.L., Lynch D.A., et al. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J Asthma 2000, 37(1):65-72.
22. Ward S., Heyneman L., Lee M.J., et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999, 173(4):937-942.
23. Agarwal R., Gupta D., Aggarwal A.N., et al. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007, 132(4):1183-1190.
24. Rosenberg M., Patterson R., Mintzer R., et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977, 86:405-414.
25. Patterson R., Greenberger P.A., Halwig J.M., et al. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986, 146(5):916-918.
26. Agarwal R., Gupta D., Aggarwal A.N., et al. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006, 130(2):442-448.
27. Imbeault B., Cormier Y. Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest 1993, 103(5):1614-1617.
28. Balter M.S., Rebuck A.S. Treatment of allergic bronchopulmonary aspergillosis with inhaled corticosteroids. Respir Med 1992, 86(5):441-442.
29. Wark P.A., Hensley M.J., Saltos N., et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003, 111(5):952-957.
30. Stevens D.A., Schwartz H.J., Lee J.Y., et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000, 342(11):756-762.
31. Skov M., Hoiby N., Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy 2002, 57(8):723-728.
32. Kanu A., Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008, 43(12):1249-1251.
33. Wark P.A., Gibson P.G., Wilson A.J. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2004, 3. CD001108.
34. van der Ent C.K., Hoekstra H., Rijkers G.T. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007, 62(3):276-277.
35. Zirbes J.M., Milla C.E. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008, 43(6):607-610.
36. Acute eosinophilic pneumonia. N Engl J Med 1990, 322(9):634-636.
37. Rosenberg H.F., Dyer K.D., Domachowske J.B. Respiratory viruses and eosinophils: exploring the connections. Antiviral Res 2009, 83(1):1-9.
38. Shenoy V.P., Vishwanath S., Indira B., et al. Hepato-pulmonary amebiasis: a case report. Braz J Infect Dis 2010, 14(4):372-373.
39. Ong R.K., Doyle R.L. Tropical pulmonary eosinophilia. Chest 1998, 113(6):1673-1679.
40. Forrester J.M., Steele A.W., Waldron J.A., et al. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis 1990, 142(2):462-467.
41. Kobashi Y., Nakajima M., Niki Y., et al. Nihon Kyobu Shikkan Gakkai Zasshi 1997, 35(12):1372-1377. [in Japanese].
42. Cottin V., Frognier R., Monnot H., et al. Chronic eosinophilic pneumonia after radiation therapy for breast cancer. Eur Respir J 2004, 23(1):9-13.
43. Rom W.N., Weiden M., Garcia R., et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002, 166(6):797-800.
44. Solomon J., Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 2006, 27(2):192-197.
45. Frankel S.K. Drug-induced lung disease. Current diagnosis and treatment in pulmonary medicine 2003, 337-347. Lange Medical Bools/McGraw-Hill, New York. M. Hanley, C. Welsh (Eds.).
46. Salerno S.M., Strong J.S., Roth B.J., et al. Eosinophilic pneumonia and respiratory failure associated with a trazodone overdose. Am J Respir Crit Care Med 1995, 152(6 Pt 1):2170-2172.
47. Fleisch M.C., Blauer F., Gubler J.G., et al. Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment. Eur Respir J 2000, 15(1):205-208.
48. Hayes D., Anstead M.I., Kuhn R.J. Eosinophilic pneumonia induced by daptomycin. J Infect 2007, 54(4):e211-e213.
49. Honore I., Nunes H., Groussard O., et al. Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis. Am J Respir Crit Care Med 2003, 167(7):953-957.
50. Paralkar V.R., Goradia A., Luger S.M., et al. Severe eosinophilia as a manifestation of acute graft-versus-host disease. Oncology 2008, 75(3-4):134-136.
51. Pandit R., Scholnik A., Wulfekuhler L., et al. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol 2007, 82(3):234-237.
52. Wilson F., Tefferi A. Acute lymphocytic leukemia with eosinophilia: two case reports and a literature review. Leuk Lymphoma 2005, 46(7):1045-1050.
53. Slungaard A., Ascensao J., Zanjani E., et al. Pulmonary carcinoma with eosinophilia. Demonstration of a tumor-derived eosinophilopoietic factor. N Engl J Med 1983, 309(13):778-781.
54. Enblad G., Sundstrom C., Glimelius B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 1993, 11(4):187-193.
55. Utsunomiya A., Ishida T., Inagaki A., et al. Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a significant unfavorable prognostic factor. Leuk Res 2007, 31(7):915-920.
56. Coultas D.B., Zumwalt R.E., Black W.C., et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994, 150(4):967-972.
57. Thomeer M.J., Costabe U., Rizzato G., et al. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J Suppl 2001, 32:114s-118s.
58. Tateno H., Nakamura H., Minematsu N., et al. Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia. Eur Respir J 2001, 17(5):962-968.
59. Alam M., Burki N.K. Chronic eosinophilic pneumonia: a review. South Med J 2007, 100(1):49-53.
60. Marchand E., Reynaud-Gaubert M., Lauque D., et al. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1998, 77:299-312.
61. Gaensler E.A., Carrington C.B. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 1977, 128:1-13.
62. Jederlinic P.J., Sicilian L., Gaensler E.A. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988, 67(3):154-162.
63. Yoshida K., Shijubo N., Koba H., et al. Chronic eosinophilic pneumonia progressing to lung fibrosis. Eur Respir J 1994, 7(8):1541-1544.
64. Marchand E., Etienne-Mastroianni B., Chanez P., et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?. Eur Respir J 2003, 22(1):8-13.
65. Durieu J., Wallaert B., Tonnel A.B. Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia. Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 1997, 10:286-291.
66. Naughton M., Fahy J., FitzGerald M.X. Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients. Chest 1993, 103(1):162-165.
67. Minakuchi M., Niimi A., Matsumoto H., et al. Chronic eosinophilic pneumonia: treatment with inhaled corticosteroids. Respiration 2003, 70(4):362-366.
68. Philit F., Etienne-Mastroianni B., Parrot A., et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002, 166(9):1235-1239.
69. Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006, 27(2):142-147.
70. Liegeon M.N., De Blay F., Jaeger A., et al. Rev Mal Respir 1996, 13(5):517-519. [in French].
71. Pope-Harman A.L., Davis W.B., Christoforidis A.J., et al. Acute eosinophilic pneumonia: a summary of fifteen cases and review of the literature. Medicine (Baltimore) 1996, 75:334-342.
72. Shintani H., Fujimura M., Ishiura Y., et al. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest 2000, 117:277-279.
73. King M.A., Pope-Harman A.L., Allen J.N., et al. Acute eosinophilic pneumonia: radiologic and clinical features. Radiology 1997, 203:715-719.
74. Tazelaar H.D., Linz L.J., Colby T.V., et al. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997, 155:296-302.
75. Churg J., Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951, 27(2):277-301.
76. Lanham J.G., Elkon K.B., Pusey C.D., et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984, 63:65-81.
77. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
78. Lane S.E., Watts R.A., Bentham G., et al. Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum 2003, 48(3):814-823.
79. Guillevin L., Cohen P., Gayraud M., et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999, 78(1):26-37.
80. Tsurikisawa N., Morita S., Tsuburai T., et al. Familial Churg-Strauss syndrome in two sisters. Chest 2007, 131(2):592-594.
81. Manganelli P., Giacosa R., Fietta P., et al. Familial vasculitides: Churg-Strauss syndrome and Wegener's granulomatosis in 2 first-degree relatives. J Rheumatol 2003, 30(3):618-621.
82. Watts R.A., Lane S.E., Bentham G., et al. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000, 43(2):414-419.
83. Harrold L.R., Andrade S.E., Go A.S., et al. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 2005, 32(6):1076-1080.
84. Loughlin J.E., Cole J.A., Rothman K.J., et al. Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients. Ann Allergy Asthma Immunol 2002, 88(3):319-325.
85. Keogh K.A., Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003, 115(4):284-290.
86. Conron M., Beynon H.L. Churg-Strauss syndrome. Thorax 2000, 55:870-877.
87. Pagnoux C., Mahr A., Cohen P., et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005, 84:115-128.
88. Kallenberg C.G. Churg-Strauss syndrome: just one disease entity?. Arthritis Rheum 2005, 52(9):2589-2593.
89. Solans R., Bosch J.A., Perez-Bocanegra C., et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford) 2001, 40(7):763-771.
90. Guillevin L., Lhote F., Gayraud M., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75(1):17-28.
91. Hasley P.B., Follansbee W.P., Coulehan J.L. Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. Am Heart J 1990, 120:996-999.
92. Morgan J.M., Raposo L., Gibson D.G. Cardiac involvement in Churg-Strauss syndrome shown by echocardiography. Br Heart J 1989, 62:462-466.
93. Ramakrishna G., Connolly H.M., Tazelaar H.D., et al. Churg-Strauss syndrome complicated by eosinophilic endomyocarditis. Mayo Clin Proc 2000, 75:631-635.
94. Stollberger C., Finsterer J., Winkler W.B. Eosinophilic pericardial effusion in Churg-Strauss syndrome. Respir Med 2005, 99:377-379.
95. Val-Bernal J.F., Mayorga M., Garcia-Alberdi E., et al. Churg-Strauss syndrome and sudden cardiac death. Cardiovasc Pathol 2003, 12:94-97.
96. Sinico R.A., Di Toma L., Maggiore U., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005, 52(9):2926-2935.
97. Sable-Fourtassou R., Cohen P., Mahr A., et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005, 143(9):632-638.
98. Choi Y.H., Im J.G., Han B.K., et al. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 2000, 117:117-124.
99. Silva C.I., Muller N.L., Fujimoto K., et al. Churg-Strauss syndrome: high resolution CT and pathologic findings. J Thorac Imaging 2005, 20:74-80.
100. Worthy S.A., Muller N.L., Hansell D.M., et al. Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. AJR Am J Roentgenol 1998, 170:297-300.
101. Katzenstein A.L. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review. Am J Clin Pathol 2000, 114(5):767-772.
102. Guillevin L., Pagnoux C., Seror R., et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine 2011, 90(1):19-27.
103. Cohen P., Pagnoux C., Mahr A., et al. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum 2007, 57(4):686-693.
104. Stone J.H., Merkel P.A., Spiera R., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363(3):221-232.
105. Metzler C., Csernok E., Gross W.L., et al. Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study. Clin Exp Rheumatol 2010, 28(1 Suppl 57):24-30.
106. Tsurikisawa N., Taniguchi M., Saito H., et al. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. Ann Allergy Asthma Immunol 2004, 92(1):80-87.
107. Arbach O., Gross W.L., Gause A. Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-alpha blockade. Immunobiology 2002, 206(5):496-501.
108. Pabst S., Tiyerili V., Grohe C. Apparent response to anti-IgE therapy in two patients with refractory "forme fruste" of Churg-Strauss syndrome. Thorax 2008, 63(8):747-748.
109. Kim S., Marigowda G., Oren E., et al. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol 2010, 125(6):1336-1343.
110. Bibby S., Healy B., Steele R., et al. Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database. Thorax 2010, 65(2):132-138.
111. Weller P.F., Plaut M., Taggart V., et al. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 2001, 108(2):175-183.
112. Klion A.D., Bochner B.S., Gleich G.J., et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006, 117(6):1292-1302.
113. Chusid M.J., Dale D.C., West B.C., et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975, 54:1-27.
114. Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med 2009, 60:293-306.
115. Ogbogu P.U., Bochner B.S., Butterfield J.H., et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009, 124(6):1319-1325. e1313.
116. Cools J., DeAngelo D.J., Gotlib J., et al. A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003, 348:1201-1214.
117. Klion A.D., Noel P., Akin C., et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003, 101(12):4660-4666.
118. Vandenberghe P., Wlodarska I., Michaux L., et al. Clinical and molecular features of FIP1L1-PDFGRA(+) chronic eosinophilic leukemias. Leukemia 2004, 18:734-742.
119. Klion A.D., Robyn J., Akin C., et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004, 103(2):473-478.
120. Curtis C.E., Grand F.H., Musto P., et al. Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia. Br J Haematol 2007, 138(1):77-81.
121. Sheikh J., Weller P.F. Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27(3):333-355.
122. Cogan E., Schandene L., Crusiaux A., et al. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994, 330:535-538.
123. Roufosse F., Cogan E., Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 2004, 59:673-689.
124. Ogbogu P.U., Rosing D.R., Horne M.K. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27(3):457-475.
125. Winn R.E., Kollef M.H., Meyer J.I. Pulmonary involvement in the hypereosinophilic syndrome. Chest 1994, 105(3):656-660.
126. Schandene L., Roufosse F., de Lavareille A., et al. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 2000, 96(13):4285-4292.
127. Verstovsek S., Tefferi A., Kantarjian H., et al. Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia. Clin Cancer Res 2009, 15(1):368-373.
128. Rothenberg M.E., Klion A.D., Roufosse F.E., et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008, 358(12):1215-1228.
129. Ochiai K., Tanabe E., Ishihara C., et al. Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma). Clin Exp Immunol 1999, 118(3):340-343.
130. Gotlib J. World health organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 2011, 86(8):677-688.
131. Jones A.V., Kreil S., Zoi K., et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005, 106(6):2162-2168.